DoD Breast Cancer, Breakthrough Fellowship Award | W81XWH 18 BCRP BFA

Opportunity Information: Apply for W81XWH 18 BCRP BFA

The DoD Breast Cancer Research Program (BCRP) Breakthrough Fellowship Award is designed to launch exceptionally promising recent PhD or MD graduates into independent careers focused on breast cancer. It funds postdoctoral fellows who want to pursue bold, high-impact ideas during their fellowship years and who can show, through past accomplishments and a strong plan, that they are among the top early-career researchers in their cohort. The central goal is not just to support another incremental study, but to help a standout fellow gain the experience, training, and research momentum needed to become a leading, independent breast cancer investigator.

A core expectation of this award is "impact." Proposed projects must have a credible path to major advances that accelerate progress toward ending breast cancer. The DoD emphasizes that the work should move beyond minor refinements and instead aim for the kind of innovation that could enable a fundamentally better approach than what is currently approved or already in clinical development. Applicants are expected to clearly define who would ultimately benefit from the research, such as specific breast cancer patient populations or individuals at elevated risk, and to connect the project to real-world needs rather than keeping it purely theoretical.

An important structural feature is that the postdoctoral fellow is the Principal Investigator (PI) for this mechanism. That means the fellow is expected to take intellectual ownership and write the major parts of the application, including the project narrative and the researcher development plan, while receiving appropriate guidance from the mentor. Prior breast cancer experience is not strictly required for the PI, but the proposed project and the training trajectory must be clearly centered on breast cancer. Reviewers will look closely at evidence that the fellow has the potential to become an independent breast cancer researcher, including the candidate's qualifications, productivity (with special weight on first-author publications), and strong letters of recommendation that speak to originality, drive, and readiness for independence.

Mentorship is treated as a make-or-break component. The mentor (or co-mentor) must bring relevant expertise in breast cancer research and/or patient care, supported by recent publications and active peer-reviewed breast cancer funding, and must show a clear commitment to developing the fellow. If the primary mentor does not have an established track record in breast cancer, the application must include a formal co-mentor who is an established breast cancer researcher. The application also needs to describe how the mentor will support innovative work and career development in practical terms. While an extensive mentoring history is helpful, a mentor with a lighter record of training pre- or postdoctoral researchers may still be acceptable if the overall researcher development plan is especially strong and well-supported by the environment.

The researcher development plan is not a formality in this program; it is a central review focus. Applicants must explain why the proposed research and training plan are well-matched to the award's purpose of building an independent, innovative breast cancer researcher. The research should be grounded in a solid scientific rationale and/or a thorough review of existing literature. Preliminary data can be included but are not required, which leaves room for genuinely new directions if the logic and feasibility are strong. The application should also describe the research environment in detail, including resources, collaborations, training opportunities, and how the setting will help the fellow build breast cancer-specific expertise. Multidisciplinary approaches are encouraged, and if the project draws on multiple fields (for example, combining oncology with immunology, engineering, data science, or behavioral science), those elements should be spelled out clearly rather than implied.

From a compliance and scope standpoint, studies involving human subjects and human anatomical substances are allowed, but clinical trials are not permitted under this announcement. Finally, the work must be relevant to Department of Defense priorities, meaning it should connect to the needs of active duty Service members, Veterans, military beneficiaries, and/or the broader American public. In other words, even highly basic or mechanistic work should be framed with a clear line of sight to breast cancer impact that matters to these populations.

Administrative details in the source notice indicate this is a discretionary DoD funding opportunity administered through the Department of Defense, Department of the Army (USAMRAA), offered as grants and/or cooperative agreements under CFDA 12.420. Eligibility is listed as unrestricted (open to any type of entity, subject to any additional eligibility clarifications in the full announcement). The opportunity referenced (W81XWH-18-BCRP-BFA) was posted in March 2018 with an original closing date of May 30, 2018, and it anticipated making about 10 awards. The listed award ceiling is shown as 0 in the summary data, which typically means applicants need to consult the full program announcement for actual budget limits and cost guidance.

• The Department of Defense, Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Breast Cancer, Breakthrough Fellowship Award" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
• This funding opportunity was created on Mar 27, 2018.
• Applicants must submit their applications by May 30, 2018. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 10 candidate(s).
• Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.

Apply for W81XWH 18 BCRP BFA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: